Sean Parker
Physician Assistant · Hidden Valley Lake, CANPI 1497221832
Payments from drug & device makers
Across 167 payments — averaging $20.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Boehringer Ingelheim$364
- Novo Nordisk$249
- Lilly USA, LLC$222
- Neurocrine Biosciences, Inc.$206
- GSK$204
- plus $944 from 13 others
What the payments were for
- Food & beverage$3,38499%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 47 | $1,212 |
| Boehringer Ingelheim | 21 | $364 |
| Novo Nordisk | 13 | $249 |
| Lilly USA, LLC | 11 | $222 |
| Neurocrine Biosciences, Inc. | 8 | $206 |
| GSK | 8 | $204 |
| Pfizer | 11 | $202 |
| AstraZeneca | 11 | $187 |
| Zealand Pharma US, Inc. | 15 | $162 |
| Bayer | 7 | $107 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $54 |
| Mylan Specialty L.p. | 3 | $52 |
| Exact Sciences | 2 | $45 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $36 |
| Johnson & Johnson | 1 | $32 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Rxsight Inc | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,401 in reported general payments places this provider in the 85th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 260 | $263,637 |
| OzempicSemaglutide | 221 | $254,101 |
| MounjaroTirzepatide | 131 | $167,101 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 155 | $121,147 |
| EliquisApixaban | 106 | $101,061 |
| TrulicityDulaglutide | 77 | $88,191 |
| Enbrel SureclickEtanercept | 11 | $80,551 |
| FingolimodFingolimod Hcl | 14 | $73,907 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 52 | $62,319 |
| XareltoRivaroxaban | 65 | $54,037 |
| MyrbetriqMirabegron | 56 | $49,593 |
| LinzessLinaclotide | 65 | $42,437 |
| FarxigaDapagliflozin Propanediol | 52 | $34,304 |
| RybelsusSemaglutide | 20 | $31,633 |
| EntrestoSacubitril/Valsartan | 17 | $30,632 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta, Stiolto Respimat, Combivent Respimat | $364 | $303,089321 claims |
| Novo NordiskOzempic, Rybelsus | $249 | $285,734241 claims |
| Lilly USA, LLCMounjaro, Trulicity | $222 | $255,292208 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $204 | $144,200210 claims |
| PfizerEliquis, Nurtec Odt, Premarin | $202 | $132,486148 claims |
| Johnson & JohnsonXarelto, Invokana | $32 | $80,47685 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $187 | $70,357115 claims |
| AbbVieLinzess, Synthroid | $1,212 | $47,314178 claims |
| BayerKerendia | $107 | $13,74211 claims |
| Eisai Inc.Dayvigo | $12 | $9,55625 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Hidden Valley Lake
- John QuigleyDowney$2.9M
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
- Eric CheungLos Angeles$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.